139 related articles for article (PubMed ID: 8785408)
1. Potential effect of metabolic acidosis on beta 2-microglobulin generation: in vivo and in vitro studies.
Sonikian M; Gogusev J; Zingraff J; Loric S; Quednau B; Bessou G; Siffert W; Drüeke TB; Reusch HP; Luft FC
J Am Soc Nephrol; 1996 Feb; 7(2):350-6. PubMed ID: 8785408
[TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin levels in patients with renal insufficiency.
Acchiardo S; Kraus AP; Jennings BR
Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-microglobulin kinetics in end-stage renal failure.
Odell RA; Slowiaczek P; Moran JE; Schindhelm K
Kidney Int; 1991 May; 39(5):909-19. PubMed ID: 2067207
[TBL] [Abstract][Full Text] [Related]
4. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines.
Campistol JM; Molina R; Bernard DB; Rodriguez R; Mirapeix E; Munoz-Gomez JM; Revert L
Am J Kidney Dis; 1993 Nov; 22(5):691-9. PubMed ID: 8238015
[TBL] [Abstract][Full Text] [Related]
6. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
[TBL] [Abstract][Full Text] [Related]
7. Deposition and removal of cutaneous beta 2-microglobulin.
Spiegel DM; Costante N; Janiga AM; Haas M; Soltani K
Am J Nephrol; 1992; 12(5):330-5. PubMed ID: 1489002
[TBL] [Abstract][Full Text] [Related]
8. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression.
Zaoui PM; Stone WJ; Hakim RM
Kidney Int; 1990 Nov; 38(5):962-8. PubMed ID: 2266681
[TBL] [Abstract][Full Text] [Related]
9. [Behavior of beta 2-microglobulin in patients undergoing blood purification].
Hou FF
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036
[TBL] [Abstract][Full Text] [Related]
10. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
11. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
12. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
[TBL] [Abstract][Full Text] [Related]
13. A study of beta 2-microglobulin skin deposits in dialyzed patients and healthy controls.
Assounga AG; Bascoul S; Canaud B; Bouya PA; Vendrell JP; Sciolla JP; Mourad G; Baldet P; Serre A; Mion C
Am J Kidney Dis; 1990 Jun; 15(6):556-61. PubMed ID: 2195873
[TBL] [Abstract][Full Text] [Related]
14. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes.
Schaefer RM; Paczek L; Heidland A
Nephrol Dial Transplant; 1991; 6 Suppl 3():53-6. PubMed ID: 1775269
[TBL] [Abstract][Full Text] [Related]
15. Patterns of metabolic acidosis in patients with chronic renal failure: impact of hemodialysis.
Cohen E; Liu K; Batlle DC
Int J Artif Organs; 1988 Nov; 11(6):440-8. PubMed ID: 3203972
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Catizone L; Cocchi R; Fusaroli M; Zucchelli P
Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
[TBL] [Abstract][Full Text] [Related]
17. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.
Oprisiu R; Bolosiu H; Boca I; Theodoru C; Elefterescu R; Brazier M; el Esper I; Leflon P; Ledeme C; Fournier A; Heinze V
Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527
[TBL] [Abstract][Full Text] [Related]
18. An unsuspected cause for metabolic acidosis in chronic renal failure: sorbent system hemodialysis.
Brezis M; Brown RS
Am J Kidney Dis; 1985 Dec; 6(6):425-7. PubMed ID: 4073022
[TBL] [Abstract][Full Text] [Related]
19. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
20. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
Mayer G; Thum J; Woloszczuk W; Graf H
Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
